Highly variable response to cytotoxic chemotherapy in carcinoma-associated fibroblasts (CAFs) from lung and breast

Overview of attention for article published in BMC Cancer, December 2008

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#40 of 8,356)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Altmetric has seen 13 news stories from 13 outlets.

GlobeNewswire 2021-11-15 BRYAN, Texas, Nov. 15, 2021 (GLOBE NEWSWIRE) -- (NYSEA:IBIO) (“iBio” or the “Company”), a developer of…

GlobeNewswire 2021-11-15 BRYAN, Texas, Nov. 15, 2021 (GLOBE NEWSWIRE) -- iBio, Inc.

Source: GlobeNewswire (MIL-OSI) BRYAN, Texas, Nov. 15, 2021 (GLOBE NEWSWIRE) — iBio, Inc.

BRYAN, Texas, Nov. 15, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 9 additional news stories.